ArticleCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees2021
SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
Article in Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein.Journal of microbiology and biotechnology · 2022Article
- Moral Distress among Frontline Physicians and Nurses in the Early Phase of COVID-19 Pandemic in Italy.International journal of environmental research and public health · 2022Article
- Article
- Photocatalytic TiOMicro and nano engineering · 2022Review
- Mind the "Vaccine Fatigue".Frontiers in immunology · 2022Review
- Article
- Vaccine design and delivery approaches for COVID-19.International immunopharmacology · 2021Review
- COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries.Infectious diseases of poverty · 2021Article
- COVID-19 vaccines and nanomedicine.International journal of dermatology · 2021Review
- An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting.Annals of medicine and surgery (2012) · 2021Article
- Review
- A Tale of Two Crises: Addressing Covid-19 Vaccine Hesitancy as Promoting Racial Justice.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2021Article
- Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.International journal of environmental research and public health · 2021Article
- Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review).International journal of molecular medicine · 2021Review
- The find of COVID-19 vaccine: Challenges and opportunities.Journal of infection and public health · 2021Review
- Ethics of Vaccination in Childhood-A Framework Based on the Four Principles of Biomedical Ethics.Vaccines · 2021Review
- Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize Performance.Frontiers in digital health · 2021Article
- A review of vaccine effects on women in light of the COVID-19 pandemic.Taiwanese journal of obstetrics & gynecology · 2020Review
- Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.European journal of pharmacology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to "normal." Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern is the potential danger to the health of human test subjects and, eventually, many vaccine recipients. This is further complicated by economic and political pressures to reduce government oversight on rushed vaccine testing and production, nationalistic distribution goals, and failure to plan for the widespread immunization needed to produce global herd immunity. As this paper asserts, the public must be better informed to assess promises about the novel vaccines being produced and to tolerate delays and uncertainty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.